We use cookies on our websites to ensure the proper functioning of the website and to help provide the best user experience.
By continuing to use our site, you agree to the use of cookies. Learn more about cookies here.

X
You appear to be from the USA. Would like to proceed to Products available in the USA?
   

Letter from EFPIA and EPHA on antimicrobial resistance

Richard Bergström, EFPIA (European Federation of Pharmaceutical Industries and Association) Director General, and Nina Renshaw, EPHA (European Public Health Alliance) Secretary General, have written an open letter on AMR to Jean-Claude Juncker, President of the European Commission. They urge European Union “to take decisive action with regard to the global threat of antimicrobial resistance (AMR), the biggest threat of the modern era to lives, health and health systems across Europe and worldwide”. According to the writers, without policy action, a post-antibiotic era could cost 10 million lives globally every year by 2050.

Reference:

Richard Bergström (EFPIA Director General), Nina Renshaw (EPHA Secretary-General). State of the Union: Open Letter from EFPIA and EPHA on AMR. 15.9.2016. http://www.efpia.eu/mediaroom/356/21/Open-Letter-from-EFPIA-and-EPHA-on-AMR

--

QuikRead go® CRP

Test before prescribing

QuikRead go CRP is a fast and simple rapid test for quantitative determination of C-reactive protein (CRP) in whole blood, serum and plasma with the QuikRead go instrument. The test gives reliable results within minutes and speeds up the path to the right diagnosis. Accurate measurement of C-reactive protein (CRP) can be critical in the clinical management of a patient with symptoms of infection. Read more: QuikRead go CRP and QuikRead go CRP+Hb